Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office Medical Dialogues Bureau3 Nov 2019 9:55 AM IST"The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a...
Much anticipated Medanta-Manipal deal comes to halt: Report Farhat Nasim20 Aug 2019 1:49 PM ISTMumbai: The much anticipated Medanta-Manipal deal worth Rs 5800 crore has come to a halt. The deal failure is reportedly the result of valuation...